Effects of Exercise Prediabetic Individuals

February 19, 2025 updated by: Ahsen Şenol, Eastern Mediterranean University

Comparison of the Effects of High-Intensity Interval Exercise Training and Moderate-Intensity Continuous Exercise Training in Prediabetic Individuals: Single-Blind Randomized Controlled Study

The aim of this study was to determine the effects of two different exercise protocols on body composition, aerobic capacity, blood lipid profile, some biomarkers, quality of life and exercise beliefs in participants at risk of diabetes.

Study Overview

Detailed Description

After being informed about the study and possible risks, all participants who gave written informed consent and met the eligibility requirements will be randomly assigned to 2 separate groups.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Mersin, Turkey, 33010
        • Recruiting
        • Eastern Mediterranean University
        • Contact:
        • Contact:
    • Kyrenia
      • Mersin, Kyrenia, Turkey, 99300

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being between 18-60 years old
  • HbA1c value between 5.7%-6.4%
  • BMI>24,9 kg/m²
  • Being sedentary
  • Not on any diet

Exclusion Criteria:

  • Insulin and derivative drug use
  • Uncontrolled hypertension
  • History of heart disease
  • History of MI or stroke

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HIIT High Intensity Interval Training
High-intensity interval training (HIIT) is a type of training that involves repeated bouts of high intensity effort interspersed by recovery times.

1 minute interval, 1 minute active recovery

5 minutes warm-up - 3 minutes cool-down will be done at 60% of peak heart rate.

Weeks 1-2: Loading at an intensity of 85% of peak heart rate, active recovery at an intensity of 60% of peak heart rate 4x1

Weeks 2-7: Loading at an intensity of 90% of peak heart rate, active recovery at an intensity of 60% of peak heart rate 6x1

Weeks 8-12: Loading at an intensity of 90% of peak heart rate, active recovery at an intensity of 60% of peak heart rate 8x1

Other Names:
  • High Intensity Interval Training
Active Comparator: MICT Moderate Intensity Continuous Training
Moderate Intensity Continuous Training (MICT) consists of performing aerobic exercise at a constant and moderate intensity for a prolonged duration.

5 minutes warm-up - 3 minutes cool-down will be done at 60% of peak heart rate.

Weeks 1-2: Loading at 65% of peak heart rate intensity (22 minute)

Weeks 2-7: Loading at 75% of peak heart rate intensity (30 minute)

Weeks 8-12: Loading at 75% of peak heart rate intensity (38 minute)

Other Names:
  • Moderate Intensity Continuous Training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HbAc
Time Frame: 12 weeks
It is the amount of glycosylated hemoglobin in the blood.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HDL
Time Frame: 12 weeks
It is the amount of high-density lipoprotein in the blood.
12 weeks
LDL level LDL
Time Frame: 12 weeks
It is the amount of low-density lipoprotein in the blood.
12 weeks
CRP
Time Frame: 12 weeks
C-reactive protein is a protein produced in the liver.
12 weeks
Total cholesterol
Time Frame: 12 weeks
Cholesterol is a lipid that is necessary for the construction of cell membranes in the body and the production of some hormones and vitamin D.
12 weeks
Triglyceride
Time Frame: 12 weeks
It is a type of fat molecule found in the bloodstream and is used as the body's energy source.
12 weeks
Irisin
Time Frame: 12 weeks
Irisin, defined as a myokine, is the proteolytic product of fibronectin type III domain 5 protein.
12 weeks
Adiponectin
Time Frame: 12 weeks
Adiponectin is a protein hormone and adipokine, which is involved in regulating glucose levels and fatty acid breakdown.
12 weeks
IL-6
Time Frame: 12 weeks
Interleukin-6 is an endogenous chemical involved in inflammation and B cell maturation.
12 weeks
Resistin
Time Frame: 12 weeks
Resistin is a hormone secreted from fat cells.
12 weeks
Kemerin
Time Frame: 12 weeks
It is a protein that is involved in many metabolic events such as adipogenesis, angiogenesis and glucose homeostasis, including the chemoattractant function of the belt.
12 weeks
Osteocalcin
Time Frame: 12 weeks
Osteocalcin is a bone-specific protein found in osteoblasts.
12 weeks
Leptin
Time Frame: 12 weeks
Leptin is a hormone that acts on the hypothalamus through negative feedback secreted from fat cells, suppressing food intake and increasing energy expenditure.
12 weeks
TNF-alpha
Time Frame: 12 weeks
Tumor necrosis factor alpha is a chemical messenger produced by the immune system that initiates inflammation.
12 weeks
Cardiometabolic risk level
Time Frame: 12 weeks
Cardiometabolic risk has been defined as a cluster of metabolic and cardiovascular abnormalities, including abdominal obesity, insulin resistance, hypertension, dyslipidemia, and atherosclerosis, that predispose individuals to cardiovascular disease and type 2 diabetes.
12 weeks
Body composition
Time Frame: 12 weeks
Body composition describes the amount of fat, bone, water and muscle in the body.
12 weeks
Aerobic capacity
Time Frame: 12 weeks
Aerobic capacity is the capacity of large striated muscle groups to adapt to work using energy obtained from aerobic metabolism.
12 weeks
Exercise Health Belief Model Scale
Time Frame: 12 weeks
Exercise Health Belief Model Scale is a 5-point Likert-type scale consists of 32 items.The scale consists of 5 factors and there is no reverse item. The highest and lowest score on the scale is 160 and 32, respectively. Higher scores indicate higher level of exercise health belief.
12 weeks
Short Form-36 Questionnaire
Time Frame: 12 weeks
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. SF-36 measures eight scales: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. High scores indicate good health status.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mehtap Malkoç, Eastern Mediterranean University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 19, 2025

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

January 29, 2025

First Submitted That Met QC Criteria

February 14, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 19, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prediabetes / Type 2 Diabetes

Clinical Trials on High Intensity Interval Training (HIIT)

Subscribe